Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 278,204 | 289,585 | 334,371 | 351,633 | 285,025 |
| Cost of Goods | 37,179 | 35,957 | 35,515 | 32,709 | 30,699 |
| Gross Profit | 241,025 | 253,628 | 298,856 | 318,924 | 254,326 |
| Operating Expenses | 214,096 | 209,019 | 256,021 | 229,052 | 214,660 |
| Operating Income | 27,108 | 45,566 | 43,350 | 90,581 | 40,365 |
| Interest Expense | 0 | 84 | 87 | 84 | 0 |
| Other Income | 3,866 | 3,930 | 188 | 945 | 2,693 |
| Pre-tax Income | 30,974 | 49,412 | 43,451 | 91,442 | 43,058 |
| Income Tax | 3,215 | 9,802 | 6,932 | 11,432 | -1,170 |
| Net Income Continuous | 27,759 | 39,610 | 36,519 | 80,010 | 44,228 |
| Minority Interests | 3 | 13 | -201 | -4 | 37 |
| Net Income | $27,756 | $39,597 | $36,720 | $80,014 | $44,191 |
| EPS Basic Total Ops | 0.29 | 0.40 | 0.36 | 0.79 | 0.44 |
| EPS Basic Continuous Ops | 0.29 | 0.40 | 0.36 | 0.79 | 0.43 |
| EPS Diluted Total Ops | 0.29 | 0.39 | 0.36 | 0.77 | 0.42 |
| EPS Diluted Continuous Ops | 0.29 | 0.39 | 0.36 | 0.77 | 0.41 |
| EBITDA(a) | $50,008 | $73,257 | $70,076 | $118,313 | $69,999 |